There are 2867 resources available
Closing remarks
Presenter: Gilles Freyer
Session: GSK - Avant-garde: Reframing the art of first-line maintenance therapy to optimise long-term outcomes in advanced ovarian cancer
Resources:
Webcast
Emerging treatment options for EGFR exon 20 insertions
Presenter: Sanjay Popat
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast
Q&A
Presenter: Paul Hofman
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast
Key learnings and closing remarks
Presenter: Maria Rosario Garcia Campelo
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast
Efficiency of eHealth and digital innovations in cancer care
Presenter: Andreas Charalambous
Session: eHealth and digital innovations
Resources:
Slides
Webcast
Development and implementation of virtual pre-chemotherapy consultations
Presenter: Catherine Oakley
Session: eHealth and digital innovations
Resources:
Slides
Webcast
CN1 - Patient-reported symptom monitoring improves health-related quality of life in lung cancer patients: The SYMPRO-Lung trial
Presenter: Nicole Billingy
Session: eHealth and digital innovations
Resources:
Abstract
CN2 - A public involvement process to enhance diversity in technology clinical trials
Presenter: Leanna Goodwin
Session: eHealth and digital innovations
Resources:
Abstract
Endometrial cancer
Presenter: Domenica Lorusso
Session: Is immunotherapy changing the standard of care in gynaecological cancers?
Resources:
Slides
Webcast
729MO - Final results of the first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in combination with nivolumab in subjects with solid tumors relapsed/refractory to prior anti-PD1/PD-L1 treatment
Presenter: Ignacio Melero
Session: Mini Oral session: Investigational immunotherapy
Resources:
Abstract
Slides
Webcast